Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
198 Leser
Artikel bewerten:
(0)

3D Cell Cultures: Technologies and Global Markets - Research and Markets

DUBLIN, June 8, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "3D Cell Cultures: Technologies and Global Markets" report to their offering.

Logo

The scope of the report encompasses the major types of 3D cell culture that have been used, as well as the major applications being developed by industry, academic researchers and their commercialization offices, and government agencies.

It analyzes current market status, examines future market drivers and presents forecasts of growth over the next five years. Technology developments, including the latest trends, are discussed. Other influential factors such as screening strategies for pharmaceuticals have also been included.

Report Includes:

  • An overview of the global markets and technologies for 3D cell cultures.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Information on 3D technologies, with a focus on representative platforms, including cube, spherical droplet, stacked plate, magnetic bead, and other platforms.
  • Value-chain analysis at the following levels: key innovation or founding intellectual property, prototyping, beta testing, and research collaborations or relationship building.
  • Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities.
  • Relevant patent analysis, including recent activity and a list of key patents.
  • Profiles of major players in the industry.

Companies Mentioned

  • Agilent Technologies
  • Alpco
  • Applikon Biotechnology
  • Beckman Coulter Life Sciences
  • Biogelx Ltd.
  • Bioinspired Solutions
  • Biotime Inc.
  • Biovision Inc.
  • Cell Applications Inc.
  • Cellink
  • Cellspring
  • Corning Life Sciences
  • Cyprotex Plc
  • Cytoo Sa
  • EMD Millipore
  • Emulate Inc.
  • Epithelix Sarl
  • GE Healthcare Life Sciences
  • Plasticell Ltd.
  • Stratatech Corp.
  • Synvivo Inc.
  • Tap Biosystems
  • Tecan Group Ltd.
  • Thermo Fisher Scientific
  • Zen-Bio Inc.
  • (30+ Others)

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Market and Technology Background

4: Tissue and Cell Culture Systems Landscape

5: Research Landscape and Products Used in Three-dimensional Cell Culture

6: Three-dimensional Technologies and Basic Products

7: Three-dimensional Models for Cancer

8: Landscape for Toxicology and Drug Safety Testing

9: 3D Culture Role in Stem Cells

10: Three-dimensional Next-Generation Outloo

For more information about this report visit http://www.researchandmarkets.com/research/x74hjd/3d_cell_cultures

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.